Announcements Trials

Browse Landscape

Phase

Status

Withdrawn 1 Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Smoldering Multiple Myeloma 2 Prostatic Neoplasms 2 Monoclonal Gammopathy of Undetermined Significance 2 Uterine Cervical Neoplasms 1 Thrombocythemia, Essential 1 Stomach Neoplasms 1 Psychological Well-Being 1 Primary Myelofibrosis 1 Polycythemia Vera 1 Neoplasms 1 Myelodysplastic Syndromes 1 Multiple Myeloma 1 Motor Activity 1 Lung Neoplasms 1 Locally Advanced Cervical Cancer 1 Esophageal Neoplasms 1 Castration Sensitive Prostate Cancer 1

Interventions

Cisplatin 22 pembrolizumab 21 Carboplatin 12 Radiotherapy 11 Paclitaxel 11 Brachytherapy 11 Drug Therapy 10 Bevacizumab 9 Blood Specimen Collection 7 Colposcopy 6 Specimen Handling 5 Injections 5 toripalimab 4 Taxes 4 Surveys and Questionnaires 4 Nivolumab 4 Mass Screening 4 Human Papillomavirus DNA Tests 4 Gemcitabine 4 Chemotherapy, Adjuvant 4 Chemoradiotherapy 4 spartalizumab 3 lenvatinib 3 camrelizumab 3 aldesleukin 3 Restraint, Physical 3 Radiation 3 Fulvestrant 3 Cyclophosphamide 3 Biopsy 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Uterine Cervical Neoplasms × Curcumin × Clear all

NCT05947513 2025-04-20

CuPRAC

Addis Ababa University

Phase NA Recruiting

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡